Biotech Entrepreneur, Others Want OxyContin Case Reheard

By Kelly Knaub (April 20, 2016, 8:33 PM EDT) -- A professor and self-described "serial entrepreneur," two patent law professors and the Intellectual Property Law Association of Chicago filed separate amicus briefs at the Federal Circuit on Monday, urging the appeals court to grant Purdue Pharma LP's bid to rehear a recent decision invalidating four of its patents on the painkiller OxyContin....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!